Company
Gemelli Biotech
Precision Diagnostics for GI Diseases
Also known as Gemelli Biotech Corp
- Business model
- B2B
- Legal name
- Gemelli Biotech Corp
Claim, correct or request removal
Record updated 29 September 2026
About
Gemelli Biotech is a clinical-stage company advancing diagnostics and therapeutics for gut-based disorders. Its flagship test, IBS-Smart, identifies antibodies linked to post-infectious IBS, helping physicians distinguish IBS from other GI conditions. By translating microbiome science into practical clinical tools, Gemelli aims to personalize care for patients with chronic digestive disorders.
Funding snapshot
- Total raised
- $28.5MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $21.2M2021-12-07
Funding rounds
- Round, 2021
- $21.2M2021-12-07, SEC form D sold, 128 investors
- Round, 2019
- $5.5M2019-12-23, SEC form D sold, 85 investors
- Round, 2019
- $1.9M2019-06-14, SEC form D sold, 13 investors
Loading relationship preview